LarmorBio Press Releases - EIN Presswire - Press Release Distribution Service

Published on July 14, 2025 - 11:00 GMT

LarmorBio Presents New Research at ENDO on the Ability of MMR Technology to Assess Cardiometabolic Disease Risk

BOSTON, MA, UNITED STATES, July 14, 2025 /⁨EINPresswire.com⁩/ -- LarmorBio today announced the presentation of three groundbreaking studies at the U.S. Endocrine Society (ENDO) 2025 conference, showcasing the power of its proprietary microscale magnetic …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 17, 2025 - 11:00 GMT

LarmorBio Announces Three New Abstracts to Be Presented at the Endocrine Society 2025 Annual Meeting (ENDO)

Company Will Introduce New Proprietary MarlinMR™ System at Meeting BOSTON, MA, UNITED STATES, June 17, 2025 /⁨EINPresswire.com⁩/ -- LarmorBio™, a Massachusetts Institute of Technology (MIT) spinout pioneering the use of microscale magnetic resonance (MMR) …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 7, 2025 - 11:00 GMT

New Data Shows Strong Correlation Between Traditional Vascular Function Metrics and LarmorBio’s Oxidative Stress Test

BOSTON, MA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- A new study utilizing LarmorBio’s proprietary microscale magnetic resonance (MMR) platform presented at the European Atherosclerosis Society (EAS) meeting has demonstrated the ability of the …

Distribution channels: ...

Published on March 25, 2025 - 11:00 GMT

LarmorBio Announces Addition of Multiple New Board Members and Senior Executive Hires

Company Prepares to Scale Business with Proprietary Microscale Magnetic Resonance Technology BOSTON, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- LarmorBio, a Massachusetts Institute of Technology (MIT) start-up pioneering the use of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on March 4, 2025 - 12:00 GMT

LarmorBio Announces New Publications Demonstrating the Potential of MMR in Bioprocessing and Stem Cell Production

Proprietary Methodology Shows Potential to Improve Yield, Quality and Function of Cell Derived Therapies BOSTON, MA, UNITED STATES, March 4, 2025 /⁨EINPresswire.com⁩/ -- LarmorBio, a Massachusetts Institute of Technology (MIT) start-up pioneering the use …

Distribution channels: Healthcare & Pharmaceuticals Industry ...